Health Care Workers’ Attitudes Toward and Knowledge of the Clinical Application of Classic Psychedelics for People with Serious Illness: A Systematic Review
This systematic review of nine studies synthesised health care workers’ attitudes toward psychedelic-assisted therapy for people with serious illness and found polarised views but a general recognition of potential benefits for refractory psychological distress. Most respondents wanted more clinical education and a stronger evidence base, and identified implementation barriers that could be mitigated by team-based care and further research.
Authors
- Barta, S.
- Brooker, J.
- O’Callaghan, C.
Published
Abstract
Background
Recent research indicates that psychedelic-assisted therapy (PAT) may be a safe and effective treatment for several psychiatric disorders, including those experienced by people with serious physical illness. Understanding health care workers’ (HCWs’) attitudes and knowledge about the clinical application of psychedelics for patients with serious illness is important in progressing research and identifying factors to consider in potential future implementation of PAT.
Aim
The aim of this systematic review was to synthesize quantitative, qualitative, and mixed methods studies that explored HCWs’ attitudes and knowledge about the role of psychedelics in treating psychological distress in patients with serious illness.
Design
MEDLINE, PsycInfo, and CINAHL were searched for quantitative, qualitative, or mixed methods primary empirical studies, published in English from 2006 onward. Two reviewers independently screened articles for inclusion. The Joanna Briggs Institute (JBI) convergent approach to mixed methods systematic reviews guided synthesis of the findings of included studies. One reviewer extracted data from included studies which was checked for accuracy by another reviewer. Two reviewers independently critically appraised included studies using JBI critical appraisal tools.
Results
The review included nine studies (seven qualitative, two quantitative) conducted in four countries. Five themes were developed: Polarized views about PAT for patients with serious illness; attitudes often informed by PAT research knowledge and heuristic methods; stronger evidence base needed to increase HCWs’ confidence and support implementation of PAT; barriers may hinder PAT’s potential integration into existing care models; and team-based approach and clinical education are essential to facilitate PAT.
Conclusion
Although support for PAT varied, most HCWs perceived potential benefits in treating refractory distress, desired education about PAT, and called for further research to develop a stronger evidence base. Limitations of the review and included studies are discussed, along with implications of the findings and recommendations for future research.
Research Summary of 'Health Care Workers’ Attitudes Toward and Knowledge of the Clinical Application of Classic Psychedelics for People with Serious Illness: A Systematic Review'
Introduction
Patients with serious, life-threatening illnesses frequently experience severe psychological and existential distress—depression, anxiety, death anxiety, demoralisation, and reduced quality of life—that existing pharmacological and psychological interventions often fail to relieve in the long term. Interest in classic psychedelics (for example, LSD and psilocybin) as adjuncts to psychotherapy has re-emerged after a decades-long research hiatus, with recent randomized trials reporting reductions in anxiety and depression and sustained benefits in some cancer cohorts. Psychedelic-assisted therapy (PAT), defined as the use of psychedelic medicines together with preparatory and integrative psychotherapy, is therefore being considered as a possible option for refractory distress in people with serious illness. Barta and colleagues set out to systematically synthesise the empirical literature on health care workers' (HCWs') attitudes and knowledge about the clinical application of classic psychedelics for patients with serious illness. The review aimed to integrate quantitative and qualitative studies to identify prevailing views, perceived barriers and facilitators to implementation, and implications for education, research, and clinical practice. The review was protocol-registered (PROSPERO CRD42023390329) and reported in line with PRISMA 2020 guidance.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typemeta
- Journal
- Topics
- APA Citation
Barta, S., Brooker, J., & O’Callaghan, C. (2025). Health Care Workers’ Attitudes Toward and Knowledge of the Clinical Application of Classic Psychedelics for People with Serious Illness: A Systematic Review. Journal of Palliative Medicine, 28(6), 815-828. https://doi.org/10.1089/jpm.2024.0306
References (22)
Papers cited by this study that are also in Blossom
Byock, I. · Journal of Palliative Medicine (2018)
Kast, E. · Psychiatric Quarterly (1967)
Ross, S. · International Review of Psychiatry (2018)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Agin-Liebes, G. I., Malone, T., Yalch, M. M. et al. · Journal of Psychopharmacology (2020)
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Vargas, A. S., Luís, Â., Barroso, M. et al. · Biomedicines (2020)
Beaussant, Y., Tulsky, J., Guérin, B. et al. · Journal of Palliative Medicine (2021)
Davis, A. K., Agin-Liebes, G. I., España, M. et al. · Journal of Psychoactive Drugs (2021)
Show all 22 referencesShow fewer
Mayer, C. E., LeBaron, V. T., Acquaviva, K. D. · Journal of Psychoactive Drugs (2021)
Niles, H., Fogg, C., Kelmendi, B. et al. · BMC Palliative Care (2021)
Reynolds, L. M, Stack, A., Akroyd, A., Sundram, F. et al. · International Journal of Environmental Research and Public Health (2021)
Winkler, P., Csémy, L. · Journal of Psychoactive Drugs (2014)
Barnett, B. S., Siu, W. O., Pope Jr, H. G. · Journal of Nervous and Mental Disease (2018)
Barnett, B. S., Beaussant, Y., King, K. et al. · Journal of Psychoactive Drugs (2021)
Nutt, D. J., Erritzoe, D., Carhart-Harris, R. L. · Cell (2020)
Trope, A., Anderson, B. T., Hooker, A. R. et al. · Journal of Psychoactive Drugs (2019)
Phelps, J. · Journal of Humanistic Psychology (2017)
Nielson, E. M., Guss, J. · Journal of Psychedelic Studies (2018)
Kaelen, M., Giribaldi, B., Raine, J. et al. · Psychopharmacology (2018)
O'callaghan, C., Hubik, D. J., Psychiatry, M. et al. · Journal of Music Therapy (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.